Back
Triumph Group 10K Form
Buy
72
TGI
Triumph Group
Last Price:
15.89
Seasonality Move:
7.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-02-07 | 10Q | TGI/Triumph Group Quarterly |
| 2023-11-07 | 10Q | TGI/Triumph Group Quarterly |
| 2023-08-11 | 10Q | TGI/Triumph Group Quarterly |
| 2023-02-02 | 10Q | TGI/Triumph Group Quarterly |
| 2022-11-08 | 10Q | TGI/Triumph Group Quarterly |
| 2022-08-03 | 10Q | TGI/Triumph Group Quarterly |
Receive TGI News And Ratings
See the #1 stock for the next 7 days that we like better than TGI
TGI Financial Statistics
Sales & Book Value
| Annual Sales: | $1.19B |
|---|---|
| Cash Flow: | $-112.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.55 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 6.64000 |
|---|---|
| Net Income (TTM): | $516.46M |
| Gross Margin: | $322.84M |
| Return on Equity: | 0% |
| Return on Assets: | 31.57% |
Triumph Group Earnings Forecast
Key Triumph Group Financial Ratios
- The Gross Profit Margin over the past 30 years for TGI is 27.08%.
- The Selling, General & Administrative Expenses for TGI have been equal to 15.12% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 24.01% of Operating Income.
- The Net Earning history of TGI is 42.98% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 20 years.
Triumph Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | TGI |
| CUSIP: | 896818 |
| Website: | triumphgroup.com |
Debt
| Debt-to-Equity Ratio: | -8.03 |
|---|---|
| Current Ratio: | 2.47 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 2.3 |
|---|---|
| Forward P/E Ratio: | 18.36 |
TGI Technical Analysis vs Fundamental Analysis
Buy
72
Triumph Group (TGI)
is a Buy
Is Triumph Group a Buy or a Sell?
-
Triumph Group stock is rated a Buy
The current Triumph Group [TGI] share price is $15.90. The Score for TGI is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.